von Moltke Lisa

Insider profile

von Moltke Lisa's trades of Seres Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
252.51
Quantity 20,283 +17.1%
Value US$1,571,357
Transaction date
Planned sale
Price
216.37
Quantity 18,418 -18.3%
Value US$4,427,695
Transaction date
Planned sale
Price
241.35
Quantity 44,909 -44.8%
Value US$2,000,971
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-02-19 2025-02-18 PlS Planned sale
20,283 +17.1%
252.51
US$1,571,357
20,283 +17.1% 252.51 US$1,571,357
2024-11-19 2024-11-18 PlS Planned sale
18,418 -18.3%
216.37
US$4,427,695
18,418 -18.3% 216.37 US$4,427,695
2024-10-29 2024-10-28 PlS Planned sale
44,909 -44.8%
241.35
US$2,000,971
44,909 -44.8% 241.35 US$2,000,971
2024-08-19 2024-08-16 PlS Planned sale
973 -4.4%
0.84
US$817
973 -4.4% 0.84 US$817
2024-05-17 2024-05-15 PlS Planned sale
939 -4.7%
0.94
US$883
939 -4.7% 0.94 US$883
2024-02-16 2024-02-16 PlS Planned sale
4,400 -20.6%
1.08
US$4,752
4,400 -20.6% 1.08 US$4,752
2023-10-31 2023-10-30 PlS Planned sale
4,232 -30.8%
1.35
US$5,713
4,232 -30.8% 1.35 US$5,713